Literature DB >> 7901190

Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas.

T Suzuki1, Y Takano.   

Abstract

Thirty-eight cases of pancreatic duct cell carcinoma were examined for p53 expression and proliferating cell nuclear antigen (PCNA) by enhanced immunohistochemistry, as well as for changes in numbers of argyrophilic nucleolar organizer regions (AgNORs). Fifteen cases (39.5%) showed p53 overexpression, which tended to increase in proportion to the histopathological grading of malignancy. However, tumor stage and lymph node status were not correlated to p53 overexpression. PCNA labeling index (LI) increased with both histologically malignant grading and pathological stage, but was not correlated with lymph node status. The expression of p53 and PCNA thus did not necessarily reflect the degree of malignant development. In contrast, AgNOR number showed statistically significant correlations with these three indicators of malignancy. A comparative analysis of p53, PCNA LI and AgNOR number showed overexpression of p53 to be correlated to PCNA LI and essentially unrelated to AgNOR number. The present results thus indicate a close relation between p53 and PCNA, while AgNORs appear to be regulated separately from either of them.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901190      PMCID: PMC5919065          DOI: 10.1111/j.1349-7006.1993.tb02803.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


pancreatic duct cell carcinoma proliferating cell nuclear antigen labeling index argyrophilic nucleolar organizer region
  24 in total

1.  Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.

Authors:  W E Mercer; M T Shields; D Lin; E Appella; S J Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

2.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

3.  Allele loss on short arm of chromosome 17 in breast cancers.

Authors:  J Mackay; C M Steel; P A Elder; A P Forrest; H J Evans
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

Review 4.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

Review 5.  Nucleolar organiser regions.

Authors:  J Crocker
Journal:  Curr Top Pathol       Date:  1990

6.  Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.

Authors:  J Bártek; J Bártková; B Vojtĕsek; Z Stasková; A Rejthar; J Kovarík; D P Lane
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

7.  Expression of p53 protein in infiltrating and in-situ breast carcinomas.

Authors:  R A Walker; S J Dearing; D P Lane; J M Varley
Journal:  J Pathol       Date:  1991-11       Impact factor: 7.996

8.  Regulation of proliferating cell nuclear antigen during the cell cycle.

Authors:  G F Morris; M B Mathews
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

9.  Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies.

Authors:  B A Robbins; D de la Vega; K Ogata; E M Tan; R M Nakamura
Journal:  Arch Pathol Lab Med       Date:  1987-09       Impact factor: 5.534

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  3 in total

1.  Ductal adenocarcinoma of the pancreas: Expression of growth factor receptors, oncogenes and suppressor genes, and their relationship to pathological features, staging and survival.

Authors:  Antonio Lozano-Leon; Begona Vieites Perez-Quintela; Julio Iglesias-García; Jose Lariño-Noia; Evaristo Varo; Jeronimo Forteza; J Enrique Domínguez-Muñoz
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

2.  p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas.

Authors:  C Walker; L J Robertson; M W Myskow; N Pendleton; G R Dixon
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

3.  Association of p53 gene mutations with short survival in pancreatic adenocarcinoma.

Authors:  S Nakamori; K Yashima; Y Murakami; O Ishikawa; H Ohigashi; S Imaoka; S Yaegashi; Y Konishi; T Sekiya
Journal:  Jpn J Cancer Res       Date:  1995-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.